Apeiron, the family office of Christian Angermayer, recently launched a new $80M venture capital fund, called Presight Capital. Angermayer’s family office is the main Limited Partner (LP) of the new fund. Another investor is the discreet German Schadeberg family office.
Mainly investing in early-stage US startups
Presight Capital will be led by Angermayer and Fabian Hansen. Hansen previously was responsible for fund of fund investments of Apeiron and is based in the San Francisco area. The main focus of the new VC fund will lie on early-stage US startups. Presight wants to offer knowledge and connections to enter the European market. Furthermore, the VC has expertise in the Biotech, Software and Tech space. The previous five investments of Presight were mainly in the biotech sector. Amongst others, the fund invested in Peptilogics (which is working on drugs against resistant bacterial infections) or Terran Biosciences (drugs against mental illnesses).
$20M from Angermayer Family Office, $60M from external investors
As previously stated, Apeiron serves as the main LP and commits $20M. Angermayer is the co-founder of Ribopharma (today: Alnylam). His net worth is estimated at €400M. The remaining $60M of the fund are committed by external investors like Mike Novogratz (founder of Galaxy Digital), Moore Strategic Ventures, Nicole Junkermann (founder Winamax, Infront Sports and Media), Uma Thurman (actress) and the Schadeberg Family Office. The Schadeberg family owns Krombacher, one of Germany’s largest independent breweries. The Schadeberg wealth is estimated at €500M.
You might like these family office articles
- Allen Single Family Office Will Invest $100M In Singapore And Southeast Asia
- Organizational Structure of Single Family Offices
- Berlusconi Single Family Office Invests In Logistics Startup